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Abstract
Objective. The primary symptom of fibromyalgia is
chronic, widespread pain; however, patients report
additional symptoms including decreased concen-
tration and memory. Performance-based deficits are
seen mainly in tests of working memory and execu-
tive functioning. It has been hypothesized that pain
interferes with cognitive performance; however, the
neural correlates of this interference are still a matter
of debate. In a previous, cross-sectional study, we
reported that fibromyalgia patients (as compared
with healthy controls) showed a decreased blood
oxygen level dependent (BOLD) response related to
response inhibition (in a simple Go/No-Go task) in the
anterior/mid cingulate cortex, supplementary motor
area, and right premotor cortex.
Methods. Here in this longitudinal study, neural
activation elicited by response inhibition was
assessed again in the same cohort of fibromyalgia
patients and healthy controls using the same
Go/No-Go paradigm.
Results. A decrease in percentage of body pain dis-
tribution was associated with an increase in BOLD
signal in the anterior/mid cingulate cortex and the
supplementary motor area, regions that have previ-
ously been shown to be “hyporeactive” in this
cohort.
Conclusions. Our results suggest that the clinical
distribution of pain is associated with the BOLD
response elicited by a cognitive task. The cingulate
cortex and the supplementary motor area are criti-
cally involved in both the pain system as well as the
response inhibition network. We hypothesize that
increases in the spatial distribution of pain might
engage greater neural resources, thereby reducing
their availability for other networks. Our data also
point to the potential for, at least partial, reversibility
of these changes.
Key Words. Pain; Fibromyalgia; fMRI; Executive
Function; Response Inhibition
Introduction
Fibromyalgia (FM) is a chronic pain syndrome character-
ized by widespread nonarticular pain, stiffness, and
fatigue. Furthermore, cognitive complaints are reported
to be present in more than 90% of patients with FM
[1,2]. These complaints, known as “fibrofog” in patient
parlance and “dyscognition” in the medical literature, add
significantly to patients’ morbidity [3]. Performance-
based tests of dyscognition in FM have found deficits in
working memory, executive control, and attention
[4–8].
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Importantly, cognitive deficits have also been described in
other chronic pain syndromes, such as chronic low back
pain, neuropathic pain, and chronic pancreatitis [9,10]. A
recently published meta-analysis concluded that chronic
nonmalignant pain has a moderate, but significant detri-
mental effect on working memory performance [11]. The
neurobiological mechanisms underlying these deficits are
still poorly understood and further research is needed to
unravel effects of pain (per se), concomitant disorders,
such as depression and anxiety, and medication on cog-
nition and brain function.
Modern brain imaging has provided some insights into the
interaction between clinial pain, experimental pain, cogni-
tive performance, and the neural correlates thereof [12].
Both painful stimuli as well as cognitive tasks (e.g.,
n-back, multisource interference task, Go/No-Go, etc.)
robustly activate regions in the prefrontal cortex and supe-
rior parietal lobes, as well as the anterior cingulate cortex
(ACC), mid-cingulate cortex (MCC), supplementary motor
cortex (SMA), and the (anterior) insular cortex. Further-
more, it has been shown that painful stimuli can also
modulate the executive attention network while engaged
in a cognitive task [12,13]. These findings indicate that
both pain perception and cognitive functioning partially
rely upon overlapping structures and networks.
To date, most studies investigating the interaction
between pain and cognitive functioning use experimental
pain, enabling controlled application of various, well-
defined pain intensities. Less is known about the neural
correlates underlying the interaction between chronic pain
and cognitive performance [14,15], one reason being the
inability to modulate chronic pain in a controlled way in the
scanner environment. One way around this drawback is to
investigate pain patients longitudinally and to relate
changes in clinical pain, either induced by therapy or just
following a natural course, to changes in cognitive perfor-
mance and related brain activation [16].
In a previous, cross-sectional study, we compared brain
activity elicited by an inhibition task (Go/No-Go task) in a
group of FM patients and healthy controls (HCs) [17]. The
Go/No-Go task is a well-established neuropsychological
test that requires the study subjects to suppress a certain
motor response (for details, see below). The neural
network underlying response inhibition has been investi-
gated in a number of studies and is well characterized.
The cortical brain areas most commonly associated with
response inhibition include the premotor cortex, the right
ventrolateral cortex, as well as several regions in the
medial frontal wall (e.g., SMA, pre-SMA, MCC, and the
dorsal ACC) [18–20], making up the inhibition network.
Importantly, the simple Go/NoGo task (as applied in this
study) is easy to perform, yielding high accuracies in both
FM and HC. Accordingly, differences in brain activation
during the task must be attributed to reasons other than
performance. In the aforementioned study, comparing FM
patients and HCs, a decreased blood oxygen level depen-
dent (BOLD) response elicited by the inhibition task was
found in FM patients in the medial frontal wall (i.e., dorsal
ACC/MCC and SMA) as well as in the right premotor
cortex, despite equal performance (i.e., accuracy and
reaction times). Our findings suggested that chronic pain
in FM leads to a decrease in task-related brain activation
in interface regions (i.e., regions that participate in the
performance of multiple tasks and networks and possibly
constitute regions of limited resources), which is in line
with other studies investigating neural correlates of
impaired executive functioning in FM patients [14].
In the present study, we aimed to investigate longitudinally
changes in brain activity elicited by the same Go/No-Go
task in the same cohort of patients and HCs [17]. In this
longitudinal design, we compared brain activity during the
task at baseline, to the activity found 12 weeks later. All
FM patients and HCs took part in a larger clinical treat-
ment trial investigating the effect of exercise, relaxation,
and standard care on clinical pain, as well as perceived
locus of control. A subset of patients and HCs took part in
the Go/No-Go study to specifically investigate differences
in task-related brain activation: 1) between groups; and
2) between groups over time (group × time point
interaction—current study). The latter approach specifi-
cally asked the question whether changes in pain over
time would be associated, with changes in brain activa-
tion. We hypothesized that those patients, who had clini-
cal improvement in terms of a reduction either in pain
intensity or in percentage body area in pain (%BP), would
show an increase in inhibition-associated BOLD response
in regions previously shown to be hyporesponsive to the
Go/No-Go task, such as the premotor cortex or the dorsal
ACC/MCC region.
Methods
Subjects
Initially we had investigated 18 individuals with FM and 14
HCs [17]. All study participants were taking part in a larger
randomized controlled clinical treatment trial for FM. The
second half of the study enrolled participants in this cog-
nitive study. Participants (i.e., FM patients and HCs) per-
formed a Go/No-Go task in the scanner [21]. Findings of
brain activations associated with inhibition and differences
in brain activations between both groups (cross-sectional
study) have been previously reported [17]. Out of this
group, 18 FM patients and 14 HCs underwent the same
Go/No-Go task posttreatment (i.e., 12 weeks later).
All participants were females. The study was conducted in
accordance with the Institutional Review Boards of the
University of Michigan, and the Department of Defence
(co-sponsor). To participate in the study, individuals with
FM needed to: 1) fulfill the 1990 American College of
Rheumatology research classification criteria for FM [22];
2) be at least 18 years of age; and 3) be under the
standard medical care of a physician for FM. Participants
were ineligible if they had any of the following: 1) a severe
physical impairment (e.g., complete blindness, or deaf-
ness, paraplegia) or coexisting physical injury (e.g.,
sprained ankle, neck injury, etc.); 2) comorbid medical
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illnesses (e.g., morbid obesity, autoimmune diseases, car-
diopulmonary disorders, uncontrolled endocrine or allergic
disorders or malignancy within 2 years; 3) any present
psychiatric disorder involving a history of psychosis,
current suicide risk or attempt within 2 years of the study,
or substance abuse within 2 years; and 4) a pending
status associated with disability or the receipt of disability
compensation for less than 2 years; as well as 5) standard
exclusion criteria for magnetic resonance imaging studies.
Demographic and Clinical Data
The following clinical features were assessed: 1) demo-
graphics (i.e., age, education); 2) pain (i.e., average weekly
pain intensity and percentage bodily pain distribution); and
3) mood (i.e., depression and anxiety).
Demographics—a standardized demographics form was
used to record age and education as well as medical
status.
Clinical Pain—pain was assessed using a patient experi-
ence diary, an electronic pain diary programmed to collect
pain ratings 6–8 times per day on a real-time random
basis. Data were then aggregated to determine the weekly
average pain rating ranging between “0” for “no pain” and
“100” for “extreme pain” (the week before scan 1 and
scan 2, respectively). Participants were also asked to
complete a body mannequin similar to that used previ-
ously to assess the presence of chronic widespread pain
[23]. The mannequin was partitioned into 70 body regions
from which the percentage of body area in pain (%BP)
could be assessed (Figure 1).
Mood—State depression and state anxiety were
assessed using the Center for Epidemiological Studies—
Depression Scale (CES-D [24]) and the State-Trait Person-
ality Inventory state anxiety scale (STPI [25]), respectively.
The CES-D is a 20-item self-report instrument that was
developed by the National Institute of Mental Health to
detect major or clinical depression in adolescents and
adults in both clinical and normal populations. The CES-D
has four separate factors: 1) Depressive affect; 2) Somatic
symptoms; 3) Positive affect; and 4) Interpersonal rela-
tions. The questions are easily interpreted and address
most of the areas included in the diagnostic criteria for
Figure 1 Mannequin with 70 body regions to assess percentage of body area in pain. Participants were
asked to complete a body mannequin similar to that used previously to assess the presence of chronic
wide-spread pain (modified version, [23]). The mannequin was partitioned into 70 body regions from which
the percentage of body area in pain could be assessed.
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depression. Most commonly, a single summary score is
obtained with a cut-off of 16 used to indicate a high
degree of depressive symptoms. The STPI is an 80-item
self-report questionnaire with eight 10-item scales for
measuring state and trait anxiety, anger, depression, and
curiosity. For purposes of this study, a subset of 10 items
were used that assessed state anxiety.
Data Acquisition and Analysis
fMRI Task
A simple Go/No-Go task was used to probe response
inhibition, similar to previous studies by our group [21].
Participants were instructed to make a speeded response
to target letters (i.e., letters other than X) by pressing a
button (i.e., Go trials), but asked to make no response to
infrequent nontarget stimuli (i.e., X; No-Go trials). There
were no additional cues to increase time pressure. All
stimuli, for Go and No-Go trials, were projected to the
middle of the presentation screen; there were no differ-
ences with respect to color or font size. Stimulus duration
was 500 msec, followed by a 3,500 msec screen with a
fixation cross. There were five runs of 49 trials, each
lasting 3 minutes 24 seconds, and containing 11, 12, or
13 No-Go trials (i.e., a total of 60 No-Go trials out of 245
total trials). No-Go trials were pseudo-randomized; the
order of the stimuli remained the same across subjects
and time points. Before scanning, all participants had a
practice session of 49 trials on a desktop computer. False-
alarm rate (i.e., responding to the No-Go signal) and reac-
tion times (RTs) for correct responses were calculated as
performance measures.
MRI Data Acquisition
Whole-brain BOLD functional images were acquired on a
3.0 Tesla GE Signa scanner (Milwaukee, WI, USA) using
T2* weighted single-shot combined spiral in-out sequence
with the following parameters: TR = 2,000 msec,
TE = 30 msec, FA = 90°, FOV = 200 mm, matri × size =
64 × 64; in plane resolution = 3.12 m × 3.12 mm, and
slice thickness = 4 mm. Participants’ motion was mini-
mized using foam pads placed around the head along
with a forehead strap.
Preprocessing and Statistical Analyses
Data were quality checked, preprocessed, and analyzed
using Statistical Parametric Mapping (SPM) software
packages, version 5 (Functional Imaging Laboratories,
London, UK), running under Matlab 7.5b (Mathworks,
Sherborn, MA, USA). Preprocessing steps included
motion correction (realignment to the first image of the
time series), normalization to the standard SPM-EPI tem-
plate (generating 2 × 2 × 2 mm resolution images), and
smoothing (convolution with a 6 mm full width at half
maximum Gaussian kernel).
First-level analyses were performed using the general
linear model implemented in SPM. Three regressors of
interest were: 1) all Go trials; 2) correct No-Go trials; and
3) failed No-Go trials (= false alarms). These were con-
volved with the canonical hemodynamic response func-
tion, with event duration of 4 seconds from stimulus
presentation. Motion parameters were modeled as regres-
sors of no interest. The main first-level contrast of interest
was correct No-Go trials vs Go trials, as a model of
inhibition (contrast image = βcorrect No-Go − βGo). This con-
trast has been described in previous studies [21]. First-
level analysis was performed by linearly combining
parameter estimates over all five runs of the task. Failed
No-Go trials were not included in the analysis.
A random effect model was used for second-level analy-
ses. The following analyses were performed:
Analysis 1: A correlation analysis within the FM group,
correlating changes in clinical pain (Δclinical pain) and
changes in task-related activation pre- and posttreat-
ment (difference image: contrast imagetime point 1 − con-
trast imagetime point 2), to determine where in the brain
(within the patients’ group) changes in clinical pain were
associated with changes in BOLD response. This was
done for pain intensity (Analysis 1a) as well as for %BP
(Analysis 1b).
Analysis 2: To corroborate the results from Analysis 1,
the group of FM patients were divided via median split
into “improvers” and “nonimprovers,” yielding three
groups overall (i.e., improvers, nonimprovers, and
HCs). For the imaging data, this was done for %BP
only, as the correlation analysis (Analysis 1) yielded
significant results in a priori hypothesized regions only
for %BP (see below). Improvers had a reduction of
≥20% of bodily pain. Repeated measures analysis of
variance (ANOVA) was used to determine whether
changes over time (pre- and posttreatment) in inhibition
related BOLD response were significantly different
between the three groups, specifically between improv-
ers and HCs (Analysis 2a), as well as improvers and
nonimprovers (Analysis 2b).
In other words, the analyses comprised the following:
1. the calculation of differences in activation between
correct No-Go and Go trials in each individual at time
points 1 and 2 (= first level contrast images—2 per
study subjects),
2. calculation of difference images between time points 1
and 2 (= 1 Δ image per FM patient),
3. correlation of Δ images with changes in clinical pain
(Δclinical pain): for Δpain intensity (Analyses 1a) and Δ%BP (Analysis
1b), and
4. performance of repeated measures ANOVA with con-
trast images comparing changes over time between
FM—improvers and HC (Analysis 2a), and
FM—improvers, and FM—nonimprovers (Analysis 2b).
All statistical maps (2nd level analyses) were corrected for
multiple comparisons on the cluster level (P < 0.05),
derived from an uncorrected P < 0.005 on the voxel level,
with a cluster extent of 92 contiguous voxels, as estimated
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by the AlphaSim application (http://afni.nimh.nih.gov/afni/
doc/manual/AlphaSim), implemented in the Analysis of
Functional NeuroImages (AFNI) software.
Results
Subjects and Behavioral Data
Due to missing data and/or poor quality of the images
(e.g., motion parameters exceeding 2 mm in translation
and/or 5o in rotation), only 17 FM patients (of originally 18
at baseline) and 12 HCs (of originally 14 at baseline) were
included in this analysis. FM patients, both improvers
and nonimprovers, had significantly more clinical pain
(P < 0.001), as well as higher depression and anxiety
scores than HCs (P < 0.001), pre- and posttreatment.
Improvers did not differ significantly from nonimprovers on
measures of depression and anxiety (P > 0.2), pre- and
posttreatment. For details, see Tables 1–3.
Performance on the Go/No-Go Task
As shown in Table 1, there were, as expected, no signifi-
cant differences between the FM group and the HC group
in mean RT (552.8 vs 558 msec, respectively, t(2,26) = 0.16,
P = 0.87) and in mean false alarms (4.4 vs 2.7 false
alarms, respectively, t(2,27) = 1.29, P = 0.21) of the
Go/No-Go task posttreatment, consistent with the pre-
treatment results previously published [17].
When looking at the FM patients, neither at time point 1 nor
at time point 2 did the groups (improvers and
nonimprovers) differ significantly in pain intensity and/or
%BP. Not surprisingly, when looking at interactions, pain
intensity improvers showed a significant decrease in pain
intensity as compared with nonimprovers (P = 0.003); like-
wise, %BP improvers showed a significant decrease in
%BP as compared with nonimprovers (P < 0.001, see
Tables 2 and 3). When comparing improvers and
nonimprovers (with respect to pain intensity), improvers
had longer RTs than nonimprovers (P = 0.025) at time point
2 (Table 2); this was due to smaller SDs at time point 2 as
compared with time point 1. Importantly, improvers even
had a more pronounced decrease in RTs (Δ RTs: 48.2 ms)
as compared with nonimprovers (Δ RTs: 22.4 ms);
however, this interaction was not significant (group × time
point interaction, P = 0.38). When comparing improvers
and nonimprovers (with respect to %BP), there were no
significant group differences and interactions between
false alarms and mean RTs, pre-, or posttreatment
(Table 3). Error rates increased slightly, but not significantly
in all four groups; there was a trend that pain intensity
improvers had a less pronounced increase in error rates as
compared with nonimprovers (group × time point interac-
tion, P = 0.09).
Correlations between Go/No-Go performance and symp-
toms of pain, depression, and anxiety were calculated.
There were no significant correlations between RT or false
alarms and any other variables during either time point 1
or time point 2. Ta
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Brain Activation during Response
Inhibition—Longitudinal Analysis
Correlation analyses within the FM group (including both
improvers and nonimprovers) with changes in pain inten-
sity and %BP were performed. There was a significant
negative correlation between change in %BP and
change in BOLD activation in the left dorsal ACC/
MCC (cluster size: k = 183, r(cluster) = −0.63, r(peak
voxel) = −0.89, P < 0.05, cluster level corrected). There
were no significant correlations between pain intensity
and BOLD response in this group. To exclude a regres-
sion to the mean effect, we performed the following
analysis: a multiple regression with %BP at time point 1
and Δ eigenvariates of the activation cluster in the cin-
gulate cortex as predictors and %BP at time point 2 as
dependent variable. Adding Δ eigenvariates of the acti-
vation cluster significantly improved the model (signifi-
cance F change 0.015). The model explained 60% of the
variance (P < 0.01). For more detailed information on
peak coordinates, r-values, and cluster sizes, see
Table 4, Figure 2A and B. For a scatterplot (correlation
of Δ clinical pain and Δ task related activation), see
Figure 3.
Direct comparison of brain activation associated with
inhibition (No-Go > Go) between the improvers and HCs
(group × time point interaction, Table 4) showed a trend
for an increased activation in the improvers’ group in the
left dorsal ACC/MCC (cluster size: k = 84, P < 0.1 cluster
level corrected; Table 4, Figure 2C and D). The same
analysis (group × time point interaction) with improvers
and nonimprovers (No-Go > Go) showed a significant
increase in activation in the improvers in the left cingulate
cortex (cluster size: k = 111, P < 0.05 cluster level cor-
rected; Table 4, Figure 2E and F).
Discussion
In this longitudinal study, we sought to relate changes in
clinical pain to changes in brain activation elicited by
response inhibition in FM patients and HCs using a
Go/No-Go task. As a main result, we report, as hypoth-
esized, an increase in task-related BOLD response in the
cingulate cortex (reaching into the SMA), a region that had
previously been found to be “hyporeactive” in FM patients
when performing a Go/No-Go task. This effect was only
related to changes in %BP in pain, but not to pain inten-
sity. To our knowledge, there is only one other study that
investigated brain activation elicited by a cognitive task in
chronic pain patients within a longitudinal study design.
Seminowicz et al. reported an increase in cortical thick-
ness of the left dorsolateral prefrontal cortex (DLPFC) in
chronic back pain patients going along with a pain reduc-
tion and normalization of brain activation (in the DLPFC)
during an attention-demanding cognitive task [16]. Our
results are in line with this study, also describing an
increase in brain activity, though in a different brain region,
i.e., in the dorsal ACC/MCC, associated with a reduction
in clinical pain.
Both acute and chronic pain affect cognition [26,27]. Cog-
nitive deficits have been described in a number of chronic
pain states such as FM [5,8,28], chronic low back pain
(CLBP) [27], chronic regional pain syndrome [27], and
chronic pancreatitis [10]. Both structural and functional
brain imaging [15,29–32] have begun to shed light on
possible mechanisms underlying these deficits. Using
fMRI, Weismann-Fogel et al. investigated patients with
temporomandibular disorder (TMD) and HCs performing a
cognitive and emotional stroop task [33]. Despite nonsig-
nificant differences in performance, TMD patients showed
increased task-related activations in brain areas impli-
cated in attention (lateral prefrontal cortex), emotional pro-
cessing (amygdala, pregenual ACC), motor planning
(SMA, primary motor cortex), as well as a diminished
deactivation in the default mode network (DMN), speci-
fically the medial prefrontal cortex and the posterior
cingulate cortex, during task performance. A lack of deac-
tivation in the DMN has also been reported by Baliki et al.
in CLBP patients performing a visual attention task
(despite equal performance) [31]. In a recently published
Table 4 Task-related brain activations: cluster sizes, z-scores/r-values, and coordinates
Region
Cluster Size (Number of
Voxels)
r Values
(Peak Values)
z-score
(Peak Value)
Coordinates (MNI)
x y z
Analysis 1—Negative correlation between %BR scores (time point 2 − time point 1) and BOLD response (FM group) (time point 2 − time point 1)
L mid cingulate cortex 183 −0.89 4.43 −10 10 44
Analysis 2a: Improvers (time point 2 − time point 1) > Healthy controls (BOLD) (time point 2 − time point 1)
L mid/anterior cingulate cortex 84* n/a 3.26 0 28 24
Analysis 2b: Improvers (time point 2 − time point 1) > Nonimprovers (BOLD) (time point 2 − time point 1)
L cingulate cortex 111 n/a 3.71 −8 10 44
* Cluster just misses the apriori defined cluster extent of 92 contiguous voxels to correct for multiple comparisons and is accordingly
reported as trend.
Analysis 1: correlation analysis between changes in clinical pain (Δclinical pain) and changes in activation (difference image: contrast
imagetime point 2 − contrast imagetime point 1); Analyses 2a and 2b: factorial design (repeated measures ANOVA), with group and time point
as factors.
%BR = percentage body regions (in pain), MNI = Montreal Neurological Institute.
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study, Seo et al. demonstrated decreased performance in
FM patients as compared with HCs in a working memory
task, associated with decreased task-related brain activa-
tion in the DLPFC, inferior parietal cortex, SMA, and ven-
trolateral prefrontal cortex [14], which is consistent with
our previous findings reported by Glass et al. [17]. Inter-
estingly, a hyporeactivity of the MCC and SMA has also
been observed in FM patients in other cognitive contexts,
such as expectancy of pain [34]. Overall, the literature is
not yet conclusive and patterns of altered brain activation
related to cognition might vary between pain syndromes
and tasks, and might further depend on other factors
such as pain duration, pain distribution, and existing
comorbidities.
The medial frontal wall is reliably activated by both noci-
ceptive stimuli, as well as cognitive tasks [35–37]. The
cortical brain areas most commonly associated with
response inhibition include the premotor cortex, the right
ventrolateral cortex, as well as several regions in the
medial frontal wall (e.g., SMA, pre-SMA, and the dorsal
ACC) [18–20], making up the inhibition network. Within
this network, the cingulate cortex subserves different
aspects of task performance; activation of the ACC has
often been attributed to attention, as well as control and
error detection [38], while the MCC and the SMA have
been implicated in response selection and motor function-
ing. Importantly, with respect to pain and the interaction
between pain and cognition, it has been hypothezised that
the cingulate cortex is likely to be the most important
component of the neural system that mediates the impact
of pain-related distress on cognitive functions, (e.g., in
terms of allocation of attentional resources) [39]. Interest-
ingly, using VBM, Luerding et al. could show that in FM
patients both clinical pain and cognitive performance cor-
relate with gray matter density in neighboring regions in
the medial frontal wall [29]. Furthermore, animal models
using nerve injury to produce prolonged neuropathic pain
have demonstrated structural micro- and macro-changes
in the ACC/medial frontal wall associated with the induc-
tion of anxiety-like behavior and attention deficts [40–42].
It is unclear how these peripheral neuropathic pain models
Figure 2 BOLD response re-
lated to inhibition—changes over
time. (A and B) Analysis 1: corre-
lation analysis between changes
in clinical pain (Δclinical pain, %BR) and
changes in BOLD responsetime
point 2 − time point 1. (C and D) Analy-
sis 2a, improvers(time point 2 − time
point 1) > healthy controls(time point 2 −
time point 1). (E and F) Analysis 2b:
improvers(time point 2 − time point 1) > non-
improvers(time point 2 − time point 1);
dACC = dorsal anterior cingulate
cortex; L = left; R = right.
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relate to chronic functional pain syndromes, like FM;
however, these findings highlight the vulnerability of the
medial frontal wall to a prolonged nociceptive input, medi-
ating the effect of pain on higher cognitive functioning.
Several conceptually different, but by no means exclu-
sive, approaches have been taken to provide a theoreti-
cal framework for dyscognition in chronic pain [26], one
of which, here referred to as the network concept (or
concept of competing demands) highlights the fact that
the pain system interacts with other neural systems, such
as the executive attention network, the salience network
and the DMN. According to this concept, a hyperactive
pain system, due to ongoing pain perception (or pain
anticipation/vigilance to pain), takes up neural resources,
no longer available for other networks, and/or leads to a
malintegration of other brain networks into the pain
system [43], and subsequently to their malfunctioning.
The executive attention network (including the inhibition
network), the salience network, and the pain system
access the medial frontal wall, which might reflect a
common effect the corresponding stimuli have on the
brain, (e.g., related to attention and/or decision-making).
On the other hand, the same region might just provide
neural resources for different networks with the ability of
network switching, depending on the present task. It is
also conceivable that the cingulate cortex serves as an
interface region enabling information flow between differ-
ent networks. Overall, it is still a matter of debate whether
emotion, pain, and cognitive control are functionally seg-
regated in distinct subdivisions of the cingulate cortex or
whether they share overlapping regions such as the ante-
rior MCC constituting a hub where information about
reinforcers can be linked to the motor system responsible
for expressing affect and executing goal-directed behav-
ior [39]. In either scenario, our data highlight both
the centricity and functional dynamics of this region
in the interaction between (clinical) pain and executive
functioning.
Overall, our data not only support an important role of the
cingulate cortex in different tasks, but also suggest that
the degree of activation and the degree of integration
within different networks can support dynamic alterna-
tions depending on environmental conditions/demands
(i.e., our data suggest functional reorganization associated
with pain improvement). Strictly speaking, the term “func-
tional reorganization” describes the recruitment of neural
tissue previously not at all (or only to a lesser degree)
involved in a specific task, associated with a shift in the
cognitive process [44]. Against this background, our
findings should better be referred to as redistribution
rather than (true) reorganization, as we found changes
(increases) in regional brain activity, having been shown
active before without a shift in the underlying cognitive
process [44].
Limitations
Several limitations of this study need to be addressed.
First, the sample size is relatively small with 17 patients in
the correlation analysis, and 8 vs 14 (improvers vs HCs)
and 8 vs 9 (improvers vs nonimprovers), respectively, in
the repeated measures ANOVAs. This small study sample
also hampers treatment-specific analysis, i.e., patients’
brain activation was only analyzed with respect to pain
and changes thereof, but not with respect to the interven-
tions applied. One might argue that different interventions
possibly have different effects on task-related brain acti-
vation and indeed future studies will have to investigate
larger sample sizes, especially when interested in
treatment-specific effects on brain activation.
Second, the relation between perceived dyscognition and
test-based deficits requires further investigations. For FM,
Glass could demonstrate that the perceived degree of
dyscognition exceeds the actual deficits seen in the neu-
ropsychological tests, implying either an exacerbation by
comorbidities, such as anxiety and depression, and/or
alterations in meta-cognitive processes [45] (i.e., the
process of reflecting over and judging one’s own perfor-
mance [and the certainty with which one has performed]).
An interesting question that arises is whether, at a certain
stage, altered task-induced brain activation is more
closely related to perceived dyscognition rather than to the
performance itself. This would imply that the lack of acti-
vation, for example due to limited resources, induces
altered self-perception (of the brain’s activity), leading to
the feeling of dyscognition, while the actual test perfor-
mance is still within normal ranges. In this study, no meta-
cognitive data, e.g., questionnaires about the degree of
perceived dyscognition and perceived performance, had
been collected. Future studies should take these aspects,
i.e., task complexity, task relevance, and meta-cognition,
Figure 3 Correlation between changes in clinical
pain and changes in task-related activation in the
anterior cingulate cortex. Δ = difference between
time points 2 and 1; ACC = anterior cingulate
cortex; %BP = percentage body area in pain.
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into account when further disentangling neural correlates
of pain-associated dyscognition.
Finally, pain-related changes in brain activation in the cin-
gulate cortex were only related to %BP in pain, but not to
pain intensity. The usual focus in pain measurement in FM
is primarily pain intensity, and secondarily functional con-
structs such as pain interference, followed by temporal
features such as pain duration. Although inherent to the
concept of FM, “widespreadedness” of pain has only
recently become as important as measuring the intensity
of pain in understanding the potential mechanisms driving
the pain complaint in FM [46]. The presence and extent of
widespread pain suggest an enhanced involvement of
central nervous system processes in the development and
maintenance of chronic pain [47,48]. A leading hypothesis
regarding the importance of pain distribution posits that
impaired antinociception plays an important role in the
genesis of chronic in FM [49,50]; however, strictly speak-
ing, impaired antinociception would explain phenomena
like hyperalgesia, but not necessarily spontaneous pain.
Given that altered proprioception (eventually misinter-
preted as pain) also plays a role, one could argue that the
extent of pain distribution correlates with the extent of
proprioceptive signal gaining access to the ACC/MCC,
i.e., salience/pain network and undergoing misinterpreta-
tion. In this sense, pain distribution might be an even more
sensitive clinical marker than pain intensity to the under-
lying pathophysiological process.
Summary and Outlook
In this longitudinal study, we demonstrated that FM
patients whose clinical pain improved showed an increase
in task-related BOLD response in the cingulate cortex and
SMA, (i.e., that a preexisting regional hypoactivation is, at
least to some degree, reversible), and secondly, that the
extent to which pain decreases correlates with the
increase in task-related BOLD response. We hypothesize
that chronic pain takes up neural resources, which are
then no longer available to other networks. However, this
seems to be a reversible process, such that a decrease in
pain is associated with functional reorganization, in terms
of a normalization in task-related brain activity. As cogni-
tive deficits have also been found in other chronic pain
states, such as CLBP [30,51,52], it will be interesting to
see whether the conceptual approach put forth by this
study is also valid for other chronic pain states or whether
it is specific to FM. Furthermore, it would be of interest
whether the integration of a “shared” region into a nonpain
network can actually be used to improve clinical pain, (i.e.,
whether it is possible to use cognitive load to reduce the
ability of pain to involuntarily capture attention) [53,54].
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